Source: Annual Congress 2011 - COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gough, P. Pillai, R. Mulla (Luton, United Kingdom). Our experience of procalcitonin assay in identifying bacterial COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 571

Member's Comments

No comment yet.

Related content which might interest you: Procalcitonin use in acute exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 The role of procalcitonin as a marker of bacterial infection in COPD exacerbations requiring mechanical ventilation Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD Source: Eur Respir J 2015; 45: 76-86 Year: 2015 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Is CRP really valid acute-phase inflammation reactant in all patients with sputum bacterial positive culture in acute exacerbation of COPD? Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019 Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 An evaluation of exacerbations in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014